Increasing evidence suggests that crosstalk between ECM and TGF-β, and intracellular TGF-β signaling often exhibits crosstalk with other signals, including Jun N-terminal kinase, p38, MAPK, and NFκB, to regulate hepatic fibrosis and HCC (126). Here, TGFB1 is linked to hepatocellular carcinoma.